Search research articles
Contact Us
Filters
Showing results (941-950 of 1,007) with videos related to
Page
of 101
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 6, 2017
Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort
Basma Merhi, Theresa Shireman, Myra A Carpenter, et al.
Journal of Clinical Pharmacology
|
July 6, 2025
Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects
Jessica Chadwick, Colin Berry, Meredith A Carpenter, et al.
Blood
|
August 5, 2004
Duration of immunosuppressive treatment for chronic graft-versus-host disease
Betty L Stewart, Barry Storer, Jan Storek, et al.
Blood
|
January 26, 2011
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E D Flowers, Yoshihiro Inamoto, Paul A Carpenter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 3, 2020
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide
Kanwaldeep K Mallhi, Meera A Srikanthan, Kelsey K Baker, et al.
Blood Advances
|
August 21, 2024
Decreasing chronic graft-versus-host disease rates in all populations
Paul A Carpenter, Ted A Gooley, Julie Boiko, et al.
The Review of Scientific Instruments
|
April 6, 2021
Upgrade of the gated laser entrance hole imager G-LEH-2 on the National Ignition Facility
Hui Chen, B Golick, N Palmer, et al.
Circulation
|
April 13, 2011
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial
Andrew G Bostom, Myra A Carpenter, John W Kusek, et al.
Blood Advances
|
February 9, 2022
A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation
Courtney M Rowan, Lincoln Smith, Matthew P Sharron, et al.
Pharmacotherapy
|
May 8, 2019
Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial
C Lindsay DeVane, Jane M Charles, Ruth K Abramson, et al.
Page
of 101
Search research articles
Search
Showing results (941-950 of 1,007) with videos related to
Sort By:
Page
of 101
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 6, 2017
Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort
Basma Merhi, Theresa Shireman, Myra A Carpenter, et al.
Journal of Clinical Pharmacology
|
July 6, 2025
Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects
Jessica Chadwick, Colin Berry, Meredith A Carpenter, et al.
Blood
|
August 5, 2004
Duration of immunosuppressive treatment for chronic graft-versus-host disease
Betty L Stewart, Barry Storer, Jan Storek, et al.
Blood
|
January 26, 2011
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E D Flowers, Yoshihiro Inamoto, Paul A Carpenter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 3, 2020
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide
Kanwaldeep K Mallhi, Meera A Srikanthan, Kelsey K Baker, et al.
Blood Advances
|
August 21, 2024
Decreasing chronic graft-versus-host disease rates in all populations
Paul A Carpenter, Ted A Gooley, Julie Boiko, et al.
The Review of Scientific Instruments
|
April 6, 2021
Upgrade of the gated laser entrance hole imager G-LEH-2 on the National Ignition Facility
Hui Chen, B Golick, N Palmer, et al.
Circulation
|
April 13, 2011
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial
Andrew G Bostom, Myra A Carpenter, John W Kusek, et al.
Blood Advances
|
February 9, 2022
A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation
Courtney M Rowan, Lincoln Smith, Matthew P Sharron, et al.
Pharmacotherapy
|
May 8, 2019
Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial
C Lindsay DeVane, Jane M Charles, Ruth K Abramson, et al.
Page
of 101